Early Access — free while we kick the tires
EdgarHawk

PLYX Polaryx Therapeutics, Inc. Insider Trading

Latest: CEO Bought $360K of Shares · May 2026
1 filing analyzed · Latest 2026-05-28
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
May 2026
2026-05-28
low
Alex Keun Mo Yang Buy
Chief Executive Officer
88,453 shares
$360,004
@ $4.07
Significance 3/10

CEO Alex Keun Mo Yang bought 88,453 shares of PLYX at $4.07 via private placement; stock now $3.05, down 93.8% from 52-week high.

CEO Alex Keun Mo Yang purchased 88,453 shares at $4.07 on 2026-05-27 as part of a private placement, not an open-market discretionary buy, bringing his holdings to 24,233,249 shares. The transaction occurred amid significant stock deterioration: the company trades at $3.05, down 93.8% from its 52-week high of $48.91 and down 45.8% over the prior 30 days. Polaryx reported a negative net income of $-2,544,000 over its most recent full fiscal year, indicating unprofitability. The private placement structure limits any inference about insider conviction, as such transactions are allocated commitments rather than discretionary market timing decisions. The combination of steep valuation decline, operating losses, and a structured allocation warrants monitoring of the company's path to profitability and capital burn dynamics.

More Chemicals and Allied Products companies

Get alerts for PLYX

Add PLYX to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access